New combo therapies show promise for japanese CLL patients
NCT ID NCT05105841
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 23 times
Summary
This study tested two drug combinations (venetoclax plus obinutuzumab or ibrutinib) in 20 Japanese adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see how well the treatments worked and how safe they were. Participants received the drugs in cycles over about a year, and doctors monitored their response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL LYMPHOCYTIC LYMPHOMA (SLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center Hospital /ID# 238797
Nagoya, Aichi-ken, 464-8681, Japan
-
Duplicate_Chiba Cancer Center /ID# 238839
Chiba, Chiba, 260-8717, Japan
-
Duplicate_Hokkaido University Hospital /ID# 238377
Sapporo, Hokkaido, 060-8648, Japan
-
Duplicate_Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 233524
Nagoya, Aichi-ken, 466-8650, Japan
-
Duplicate_Jichi Medical University Hospital /ID# 238434
Shimotsuke-shi, Tochigi, 329-0498, Japan
-
Duplicate_NHO Nagoya Medical Center /ID# 233523
Nagoya, Aichi-ken, 460-0001, Japan
-
Duplicate_Okayama University Hospital /ID# 238467
Okayama, Okayama-ken, 700-8558, Japan
-
Duplicate_Osaka University Hospital /ID# 234037
Suita-shi, Osaka, 565-0871, Japan
-
Duplicate_Shimane University Hospital /ID# 234076
Izumo-shi, Shimane, 693-8501, Japan
-
Hyogo Prefectural Amagasaki General Medical Center /ID# 234082
Amagasaki-shi, Hyōgo, 660-8550, Japan
-
Kindai University Hospital /ID# 234001
Osakasayama-shi, Osaka, 589-8511, Japan
-
Kyushu University Hospital /ID# 238437
Fukuoka, Fukuoka, 812-8582, Japan
-
National Cancer Center Hospital /ID# 232449
Chuo-ku, Tokyo, 104-0045, Japan
-
National Hospital Organization Shikoku Cancer Center /ID# 234059
Matsuyama, Ehime, 791-0280, Japan
-
Niigata University Medical & Dental Hospital /ID# 238324
Niigata, Niigata, 951-8520, Japan
-
The Cancer Institute Hospital Of JFCR /ID# 232450
Koto-ku, Tokyo, 135-8550, Japan
-
Tohoku University Hospital /ID# 238433
Sendai, Miyagi, 9808574, Japan
-
Tokai University Hospital /ID# 238970
Isehara, Kanagawa, 259-1193, Japan
-
University Hospital Kyoto Prefectural University of Medicine /ID# 239883
Kyoto, Kyoto, 602-8566, Japan
-
Yamagata University Hospital /ID# 234032
Yamagata, Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.